Skip to main content
NIH funding notice PAR-18-712

Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)

Closed on May 7, 2021.

Posted
March 15, 2018
Close date
May 7, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

11 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,097,084 in first-year total cost, median $464,445.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IMM-K (52)]5
  2. Cellular and Molecular Immunology - B Study Section[CMIB]2
  3. Special Emphasis Panel[ZRG1 IDIB-N (90)]1
  4. Special Emphasis Panel[ZRG1 IMM-N (52)]1
  5. Special Emphasis Panel[ZRG1 IMM-N (90)]1

Most frequent institutions

  1. ROCKEFELLER UNIVERSITY4
  2. CHILDREN'S HOSP OF PHILADELPHIA1
  3. COLUMBIA UNIVERSITY HEALTH SCIENCES1
  4. DANA-FARBER CANCER INST1
  5. UNIVERSITY OF CALIFORNIA LOS ANGELES1
Competing awards under PAR-18-712 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Collaborative multi-site project to speed the identification and management of rare genetic immune diseases1R01AI153827-01A1BUTTE, MANISH JPASANIUC, BOGDANUNIVERSITY OF CALIFORNIA LOS ANGELES, CA$806,368ZRG1
2021GENETIC, IMMUNOLOGIC AND MECHANISTIC BASIS OF HUMAN NK CELL DEFICIENCY2R01AI120989-07ORANGE, JORDAN SCOTTCOLUMBIA UNIVERSITY HEALTH SCIENCES, NY$784,972CMIB
2021Inborn errors of immunity in patients with life-threatening COVID-191R01AI163029-01CASANOVA, JEAN-LAURENTZHANG, QIANZHANG, SHEN-YINGROCKEFELLER UNIVERSITY, NY$762,750ZRG1
2021Genome-Wide Dissection of Mendelian Susceptibility to Mycobacterial Disease2R01AI095983-11BUSTAMANTE, JACINTACASANOVA, JEAN-LAURENTROCKEFELLER UNIVERSITY, NY$508,500ZRG1
2021Development, Optimization and Preclinical Modeling of Hematopoietic Stem Cell Gene Editing for the Treatment of RAG1 Immunodeficiency1R01AI155796-01A1GENOVESE, PIETRODANA-FARBER CANCER INST, MA$441,100TTT
2021Mechanisms driving extrafollicular polyreactive B cell lineages in partial RAG deficiency1R01AI153830-01A1WALTER, JOLAN ESZTERUNIVERSITY OF SOUTH FLORIDA, FL$440,669CMIB
2020Inborn errors of immunity in children with herpes simplex encephalitis2R01AI088364-11CASANOVA, JEAN-LAURENTZHANG, SHEN-YINGROCKEFELLER UNIVERSITY, NY$464,445ZRG1
2020Coding and Noncoding RNA Contributions to 22q11.2 Deletion Syndrome2R01AI114523-06A1VAN OERS, NICOLAI STANISLAS CYRILLEUT SOUTHWESTERN MEDICAL CENTER, TX$432,807ZRG1
2020Mechanisms of R loop-mediated genome instability in Wiskott-Aldrich syndrome1R01AI146380-01A1VYAS, YATIN MUNIVERSITY OF IOWA, IA$424,875ZRG1
2020Molecular and cellular basis of epidermodysplasia verruciformis1R01AI143810-01A1CASANOVA, JEAN-LAURENTJOUANGUY, EMMANUELLEUITTO, JOUNIROCKEFELLER UNIVERSITY, NY$424,250ZRG1
2019Promoter interactome-aided mapping of unexplored CVID genetic landscapes1R01AI146026-01ROMBERG, NEIL DAVIDCHILDREN'S HOSP OF PHILADELPHIA, PA$606,348ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-18-712: Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed) | ScienceDex | ConductScience